Please do not adjust margins
Organic & Biomolecular Chemistry
Page 4 of 4
ARTICLE
Organic and Biomolecular Chemistry
17 (a) G. M. Atkins and E. M. Burgess J. Am. Chem. Soc. 1968,
Conclusions
90, 4744; (b) E. M. Burgess, H. R. RenDtoOnI: 1a0n.1d03E9./AC6. OTBa0y1lo73r8JJ.
Org. Chem. 1973, 38, 26.
The synthesis presented here allows the preparation of all
three hortonones in 12-15 steps from the readily available
Inhoffen-Lythgoe diol. This study has revealed that the
absolute configuration of the hortonones is opposite that
originally proposed by Andersen at al. (Figure 3),1 and thus
vitamin D2 is not a likely biosynthetic precursor of this family
of natural products. A synthetic route to (+)-hortonones A-C
from an alternate starting material is currently being
investigated and our findings will be reported in due course.
18 E. Brandes, P. A. Grieco and P. Garner J. Chem. Soc., Chem
Commun. 1988, 7, 500.
19 (a) G. Buchi and J. C. Vederas J. Am. Chem. Soc. 1972, 94,
9129. (b) K.H. Schulte-Elte, B. L. Muller and G. Ohloff Helv.
Chim. Acta 1973, 56, 309.
20 (a) C. Fehr and O. Guntern Helv. Chim. Acta 1992, 75, 1023.
(b) C. Fehr, J. Galindo and O. Guntern Tetrahedron Lett.
1990, 28, 4021. (c) S. Serra and C. Fuganti Tetrahedron
Asymm. 2006, 17, 1573.
21 D. G. Morris Chem. Soc. Rev. 1982, 11, 397.
22 (a) L. A. Sarandeses, A. Mourino and J.-L. Luche J. Chem. Soc.,
Chem. Commun. 1981, 818. (b) D. Liotta and G. Zima J. Org.
Chem. 1980, 45, 2551.
Acknowledgements
This communication is dedicated to Professor Peter B. Dervan
on the occasion of his 70th birthday. The authors thank Jason
Lee for his preparation of compound 4. We acknowledge the
National Science Foundation (CHE-1508070), the National
Institutes of Health (SC3 GM 096899-01) and the donors of the
American Chemical Society Petroleum Research Fund (53693-
URI) for their generous support of this research.
Notes and references
1
G. Carr, D. E. Williams, R. Ratnayake, R. Bandara, S.
Wijesundara, T. Tarling, A. D. Balgi, M. Toberge, R. J.
Andersen and V. Karunaratne J. Nat. Prod. 2012, 75, 1189.
(a) A. M. DeBerardinis, S. Lemieux and M. K. Hadden Bioorg.
Med. Chem. Lett. 2013, 23, 5367; (b) D. Meyer, L. Rentsch
and R. Marti, RSC Advances 2014, 4, 32327; (c) U. Banerjee,
A. M. DeBerardinis and M. K. Hadden Bioorg. Med. Chem.
2015, 23, 548.
2
3
4
M. Lamblin, D. Dabbas, R. Spingarn, R. Mendoza-Sanchez, T.
Wang, B. An, D. C. Huang, R. Kremer, J. H. White and J. L.
Gleason Bioorg. Med. Chem. 2010, 18, 4119.
V. VanRheenen, R. C. Kelly and D. Y. Cha Tetrahedron Lett.
1976, 17, 1973.
5
6
D. B. Dess and J. C. Martin J. Org. Chem. 1983, 48, 4155.
P.E. Peterson, R. L. Breedlove Leffew and B. L. Jensen J. Org.
Chem. 1986, 51, 1948.
7
8
Y. Ito, S. Fujii, M. Nakatsuka, F. Kawamoto and T. Saegusa
Org Syn, 1980, 59, 113.
(a) T. Kreuzer and P. Metz Eur. J. Org. Chem. 2008, 3, 572; (b)
T. Uyehara, Y. Kabasawa, T. Kato and T. Furuta Tetrahedron
Lett. 1985, 26, 2343.
9
Y. Ito, T. Hirao and T. Saegusa J. Org. Chem. 1978, 43, 1011.
10 (a) P. S. Wharton and D. H. Bohlen J. Org. Chem. 1961, 26,
3615; (b) H. –J. Liu and H. Wynn Can J. Chem. 1986, 64, 658.
11 (a) X. C. Gonzalez-Avion, A. Mourino, N. Rochel and D. Moras
J. Med. Chem. 2006, 49, 1509. (b) A. Yasuda, H. Yamamoto
and H. Nozaki Bull. Chem. Soc. Jpn. 1979, 52, 1757. (c) A.
Yasuda, H. Yamamoto and H. Nozaki Tetrahedron Lett. 1976,
49, 2621.
12 V. Dambrin, M. Villieras, P. Janvier, L. Toupet, H. Amri, J.
Lebreton and J. Villieras Tetrahedron 2001, 57, 2155.
13 N. Asao, S. Lee and Y. Yamamoto Tetrahedron Lett. 2003, 44,
4265.
14 For a recent review of 1,3-oxidative transpositions, see: F. A.
Luzzio Tetrahedron 2012, 68, 5323.
15 F. Yoshimura, M. Sasaki, I. Hattori, K. Komatsu, M. Sakai, K.
Tanino and M. Miyashita Chem. Eur. J. 2009, 15, 6626.
16 C. Zeng, J. Zhao and G. Zhao Tetrahedron 2015, 71, 64.
4 | Org. Biomol. Chem., 2012, 00, 1-3
This journal is © The Royal Society of Chemistry 20xx
Please do not adjust margins